Literature DB >> 20463440

Old age as an "alternative" to illness: gerontological and medico-legal aspects.

Andrea Molinelli1, Laura Viale, Maria Celeste Landolfa, Francesco De Stefano.   

Abstract

The current trend toward an ever increasing aging population forces society to face the problem of how to care for elderly people who are exposed to the risk of so-called "elder abuse," a phenomenon becoming increasingly widespread in Italy, as legislation does not provide a precise juridical definition of "elderly" nor does it provide for their specific protection. From a geriatric and medico-legal point of view, it is difficult to assess the cognitive performance of elderly individuals due to a number of factors, including the lack of evaluation tools with well-defined reference parameters for assessing decision-making capacities. Nonetheless, according to Italian penal code, abandoning a person incapable of self-support due to old age is considered a violation of the obligation of family assistance. Just as in the USA, which has instituted the Adult Protective Services, the Authors propose that the local health authorities provide help desks for the victims of elder abuse in Italy.

Entities:  

Mesh:

Year:  2010        PMID: 20463440     DOI: 10.3275/7042

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  2 in total

1.  Validation of the Italian Version of the Caregiver Abuse Screen among Family Caregivers of Older People with Alzheimer's Disease.

Authors:  Maria Gabriella Melchiorre; Mirko Di Rosa; Francesco Barbabella; Norma Barbini; Fabrizia Lattanzio; Carlos Chiatti
Journal:  Biomed Res Int       Date:  2017-02-07       Impact factor: 3.411

Review 2.  Elder abuse in Europe's "most elderly" city: an update of the phenomenon based on the cases reported to the Penal Court of Genoa from 2015 to 2019 and literature review.

Authors:  Martina Drommi; Alessandra Ponte; Francesco Ventura; Andrea Molinelli
Journal:  Aging Clin Exp Res       Date:  2021-01-31       Impact factor: 3.636

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.